Noschese P - Search Results

1

Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone.

Cazzola M, Noschese P, Di Perna F. Cazzola M, et al. Among authors: noschese p. Ther Adv Respir Dis. 2009 Apr;3(2):59-63. doi: 10.1177/1753465809104677. Epub 2009 May 14. Ther Adv Respir Dis. 2009. PMID: 19443519 Free article. Clinical Trial.

2

Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD.

Cazzola M, Noschese P, Centanni S, Santus P, Di Marco F, Spicuzza L, Di Maria GU. Cazzola M, et al. Among authors: noschese p. Pulm Pharmacol Ther. 2004;17(3):141-5. doi: 10.1016/j.pupt.2004.01.004. Pulm Pharmacol Ther. 2004. PMID: 15123223 Clinical Trial.

3

Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.

Cazzola M, Noschese P, Salzillo A, De Giglio C, D'Amato G, Matera MG. Cazzola M, et al. Among authors: noschese p. Respir Med. 2005 May;99(5):524-8. doi: 10.1016/j.rmed.2004.10.004. Epub 2004 Nov 26. Respir Med. 2005. PMID: 15823447 Free article. Clinical Trial.

4

Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.

Cazzola M, Salzillo A, De Giglio C, Piccolo A, Califano C, Noschese P. Cazzola M, et al. Among authors: noschese p. Respir Med. 2005 Jun;99(6):663-9. doi: 10.1016/j.rmed.2004.11.007. Epub 2005 Jan 13. Respir Med. 2005. PMID: 15878482 Free article.

5

Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.

Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG. Cazzola M, et al. Among authors: noschese p. Eur Respir J. 1998 Jun;11(6):1337-41. doi: 10.1183/09031936.98.11061337. Eur Respir J. 1998. PMID: 9657576 Free article. Clinical Trial.

6

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.

Cazzola M, Noschese P, De Michele F, D'Amato G, Matera MG. Cazzola M, et al. Among authors: noschese p. Respir Med. 2006 Feb;100(2):212-7. doi: 10.1016/j.rmed.2005.04.024. Epub 2005 Jun 3. Respir Med. 2006. PMID: 15936184 Free article. Clinical Trial.

7

[Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].

Cazzola M, Noschese P, Vinciguerra A, Di Perna F, Califano C, Berra A. Cazzola M, et al. Among authors: noschese p. Minerva Med. 1998 Jan-Feb;89(1-2):15-22. Minerva Med. 1998. PMID: 9561021 Italian.

8

Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma.

Cazzola M, Noschese P, D'Amato M, D'Amato G. Cazzola M, et al. Among authors: noschese p. Chest. 2000 Nov;118(5):1322-6. doi: 10.1378/chest.118.5.1322. Chest. 2000. PMID: 11083681

9

Parenteral antibiotic therapy in the treatment of lower respiratory tract infections. Strategies to minimize the development of antibiotic resistance.

Cazzola M, Matera MG, Noschese P. Cazzola M, et al. Among authors: noschese p. Pulm Pharmacol Ther. 2000;13(6):249-56. doi: 10.1006/pupt.2000.0253. Pulm Pharmacol Ther. 2000. PMID: 11061979 Review.

10

Asthma treatment must be always tailored to the individual patient.

Cazzola M, Noschese P, Salzillo A, Piccolo A. Cazzola M, et al. Among authors: noschese p. Monaldi Arch Chest Dis. 2002 Jun-Aug;57(3-4):213-7. Monaldi Arch Chest Dis. 2002. PMID: 12619388 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page